ABCB1 and cancer: PANC-1 pancreatic cancer cells are shown to be resistant to doxorubicin by a MDR phenotype caused by overexpression of P-glycoprotein (Pgp) efflux pumps that prevent doxorubicin from accumulating within the cancer cells (Figure 8B, black square).